Your browser doesn't support javascript.
loading
Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma.
Rangwala, Reshma; Leone, Robert; Chang, Yunyoung C; Fecher, Leslie A; Schuchter, Lynn M; Kramer, Amy; Tan, Kay-See; Heitjan, Daniel F; Rodgers, Glenda; Gallagher, Maryann; Piao, Shengfu; Troxel, Andrea B; Evans, Tracey L; DeMichele, Angela M; Nathanson, Katherine L; O'Dwyer, Peter J; Kaiser, Jonathon; Pontiggia, Laura; Davis, Lisa E; Amaravadi, Ravi K.
Affiliation
  • Rangwala R; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Leone R; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Chang YC; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Fecher LA; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Schuchter LM; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Kramer A; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Tan KS; Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia, PA USA.
  • Heitjan DF; Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia, PA USA.
  • Rodgers G; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Gallagher M; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Piao S; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Troxel AB; Center for Clinical Epidemiology and Biostatistics; University of Pennsylvania; Philadelphia, PA USA.
  • Evans TL; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • DeMichele AM; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Nathanson KL; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • O'Dwyer PJ; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
  • Kaiser J; Philadelphia College of Pharmacy; University of the Sciences; Philadelphia, PA USA.
  • Pontiggia L; Department of Mathematics, Physics and Statistics; University of the Sciences; Philadelphia, PA USA.
  • Davis LE; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA; Philadelphia College of Pharmacy; University of the Sciences; Philadelphia, PA USA.
  • Amaravadi RK; Department of Medicine and Abramson Cancer Center; University of Pennsylvania; Philadelphia, PA USA.
Autophagy ; 10(8): 1369-79, 2014 Aug.
Article in En | MEDLINE | ID: mdl-24991839
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Dacarbazine / Hydroxychloroquine / Melanoma / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Autophagy Year: 2014 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Dacarbazine / Hydroxychloroquine / Melanoma / Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Autophagy Year: 2014 Document type: Article Country of publication: United States